Literature DB >> 25908474

Our own worst enemy: pharmacologic mechanisms of hypertension.

Lynn E Kassel1, Lauren E Odum2.   

Abstract

Drug-induced hypertension is often an unrecognized cause of resistant or secondary hypertension. It is defined as hypertension resulting from the unintended effect of a drug or from a drug's antagonistic effect on antihypertensive medications. The main mechanisms of drug-induced hypertension, when categorized broadly, include volume retention and sympathomimetic effects. These mechanisms along with management strategies will be further discussed in this article.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood pressure; Drug induced; Hypertension; Resistant hypertension; Secondary hypertension

Mesh:

Substances:

Year:  2015        PMID: 25908474     DOI: 10.1053/j.ackd.2014.10.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  5 in total

Review 1.  Drug-Induced Hypertension: Focus on Mechanisms and Management.

Authors:  Alexandra R Lovell; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

Review 2.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

Review 3.  Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects.

Authors:  Samuel J Jurca; William J Elliott
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

Review 4.  A Revolutionary Blueprint for Mitigation of Hypertension via Nanoemulsion.

Authors:  Girish Kumar; Tarun Virmani; Kamla Pathak; Abdulsalam Alhalmi
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

5.  Antenatal exposure to nonsteroidal anti-inflammatory drugs and risk of neonatal hypertension.

Authors:  Mounira Habli; Corey C Clifford; Tammy M Brady; Zahidee Rodriguez; Michaela Eschenbacher; Malcolm Wu; Emily DeFranco; James Gresh; Beena D Kamath-Rayne
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-27       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.